These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 33306980)

  • 21. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine trials must include helminth-infected cohorts.
    Egwang TG; Owalla TJ; Kemigisha M
    Nat Immunol; 2022 Feb; 23(2):148. PubMed ID: 35075281
    [No Abstract]   [Full Text] [Related]  

  • 24. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum.
    Vashishtha VM; Kumar P
    Indian J Med Ethics; 2021; VI(1):1-3. PubMed ID: 34080991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
    Jhaveri R
    Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.
    Funk CD; Laferrière C; Ardakani A
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine-induced protection in aging adults and pandemic response.
    Schenkelberg T
    Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
    [No Abstract]   [Full Text] [Related]  

  • 29. An immunologist's perspective on anti-COVID-19 vaccines.
    Milota T; Strizova Z; Smetanova J; Sediva A
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):545-552. PubMed ID: 34545040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 32. Peruvian COVID-19 vaccine scandal spreads.
    Chauvin L
    Lancet; 2021 Feb; 397(10276):783. PubMed ID: 33640052
    [No Abstract]   [Full Text] [Related]  

  • 33. Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.
    Su S; Shao Y; Jiang S
    Emerg Microbes Infect; 2021 Dec; 10(1):439-441. PubMed ID: 33635184
    [No Abstract]   [Full Text] [Related]  

  • 34. The COVID-19 vaccine development: A pandemic paradigm.
    Carneiro DC; Sousa JD; Monteiro-Cunha JP
    Virus Res; 2021 Aug; 301():198454. PubMed ID: 34015363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do health-care workers need a COVID-19 vaccine booster?
    Cirillo N
    Lancet Infect Dis; 2022 Jan; 22(1):20. PubMed ID: 34953546
    [No Abstract]   [Full Text] [Related]  

  • 36. Viral targets for vaccines against COVID-19.
    Dai L; Gao GF
    Nat Rev Immunol; 2021 Feb; 21(2):73-82. PubMed ID: 33340022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
    Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative Role of Vitamin D for COVID-19 Vaccination.
    Chiu SK; Tsai KW; Wu CC; Zheng CM; Yang CH; Hu WC; Hou YC; Lu KC; Chao YC
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
    Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.